Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction: Results from the PROMIS-HFpEF Study

Skip to content
Skip to navigation
Skip to footer

R&D /CVRM

09 October 2020 Details

Published:

Circulation

AstraZeneca author(s):

Li-Ming Gan Show all authors Maria Lagerström Fermer

Related Content:

Making the connection: Targeting multiple mechanisms in heart failure